GLP Inhibitor use is on the rise, which is great for patients but not so great for physical therapists burdened with questions. One of the biggest concerns right now with GLP inhibitor use is the loss of fat free muscle mass, usually in the form of muscle mass. This is an obvious concern to the PTs and exercise science community in general. Should we be concerned? Listen to our most recent video here or check out the transcript below:

0:00) Good afternoon, Dr. Wells here today to talk to you about a new article, really a commentary, (0:05) in this month's JAMA by Conte, Hall, and Klein. It was really a study or commentary on the new (0:13) GLP inhibitors, Ozempic and Wigovi. They're very popular right now for weight loss, and probably (0:18) one of the biggest concerns that a lot of people are talking about is that people lose fat-free (0:23) mass while taking these drugs.

Well, no surprise, the authors found that individuals that are obese (0:29) actually have larger amounts of s...